NASDAQ:MGLN - Magellan Health Stock Price, News, & Analysis

$65.95
+0.47 (+0.72 %)
(As of 06/17/2019 02:49 PM ET)
Today's Range
$65.26
Now: $65.95
$66.02
50-Day Range
$64.15
MA: $67.80
$70.98
52-Week Range
$51.88
Now: $65.95
$99.90
Volume5,026 shs
Average Volume185,395 shs
Market Capitalization$1.59 billion
P/E Ratio26.99
Dividend YieldN/A
Beta0.52
Magellan Health, Inc provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. Read More…

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$7.31 billion
Cash Flow$8.1119 per share
Book Value$52.99 per share

Profitability

Net Income$24.18 million

Miscellaneous

Employees10,500
Market Cap$1.59 billion
Next Earnings Date7/26/2019 (Estimated)
OptionableOptionable

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health Inc (NASDAQ:MGLN) issued its earnings results on Thursday, May, 2nd. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.34 by $0.06. The company earned $1.74 billion during the quarter, compared to analyst estimates of $1.75 billion. Magellan Health had a return on equity of 3.83% and a net margin of 0.18%. The business's revenue was down 3.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.81 EPS. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Friday, July 26th 2019. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health updated its FY19 earnings guidance on Thursday, May, 2nd. The company provided earnings per share (EPS) guidance of $3.70-4.69 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.92. The company issued revenue guidance of $7.0-7.2 billion, compared to the consensus revenue estimate of $7.22 billion.

What price target have analysts set for MGLN?

4 Wall Street analysts have issued 1-year price targets for Magellan Health's stock. Their forecasts range from $68.00 to $84.00. On average, they expect Magellan Health's stock price to reach $73.50 in the next year. This suggests a possible upside of 11.4% from the stock's current price. View Analyst Price Targets for Magellan Health.

What is the consensus analysts' recommendation for Magellan Health?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Magellan Health in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Magellan Health.

Has Magellan Health been receiving favorable news coverage?

News coverage about MGLN stock has been trending somewhat positive on Monday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Magellan Health earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for Magellan Health.

Who are some of Magellan Health's key competitors?

What other stocks do shareholders of Magellan Health own?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman, CEO & CEO of Magellan Healthcare (Age 65)
  • Mr. Jonathan Neal Rubin, Chief Financial Officer (Age 55)
  • Mr. Daniel Norman Gregoire, Gen. Counsel & Sec. (Age 63)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 38)
  • Ms. Renie Shapiro Silver, SVP - Corp. Fin.

Who are Magellan Health's major shareholders?

Magellan Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (3.04%), Parametric Portfolio Associates LLC (1.20%), William Blair Investment Management LLC (0.81%), JPMorgan Chase & Co. (0.80%), Smith Graham & Co. Investment Advisors LP (0.71%) and 13D Management LLC (0.63%). Company insiders that own Magellan Health stock include Barry M Smith, Clapper Caskie Lewis, Daniel N Gregoire, Jeffrey N West, Jonathan N Rubin and Mostafa Kamal. View Institutional Ownership Trends for Magellan Health.

Which institutional investors are selling Magellan Health stock?

MGLN stock was sold by a variety of institutional investors in the last quarter, including LSV Asset Management, Kennedy Capital Management Inc., Victory Capital Management Inc., Marshall Wace LLP, William Blair Investment Management LLC, First Quadrant L P CA, Cambiar Investors LLC and New York State Teachers Retirement System. View Insider Buying and Selling for Magellan Health.

Which institutional investors are buying Magellan Health stock?

MGLN stock was bought by a variety of institutional investors in the last quarter, including 13D Management LLC, 13D Management LLC, Parametric Portfolio Associates LLC, Assenagon Asset Management S.A., FMR LLC, JPMorgan Chase & Co., SG Americas Securities LLC and Alpine Associates Management Inc.. View Insider Buying and Selling for Magellan Health.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $65.95.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $1.59 billion and generates $7.31 billion in revenue each year. The company earns $24.18 million in net income (profit) each year or $2.44 on an earnings per share basis. Magellan Health employs 10,500 workers across the globe.View Additional Information About Magellan Health.

What is Magellan Health's official website?

The official website for Magellan Health is http://www.magellanhealth.com/.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (NASDAQ MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  306 (Thanks for Voting!)
Underperform Votes:  312 (Thanks for Voting!)
Total Votes:  618
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel